Discovery of Lu AF58801, a novel, selective and brain penetrant positive allosteric modulator of alpha-7 nicotinic acetylcholine receptors: Attenuation of subchronic phencyclidine (PCP)-induced cognitive deficits in rats following oral administration
Jesper F. Bastlund(Lundbeck (Denmark)), Jørgen Eskildsen(Lundbeck (Denmark)), Roger L. Papke(Io Therapeutics (United States)), John P. Redrobe(Douglas Mental Health University Institute), Kristen Frederiksen(Mayo Clinic in Florida), Christoffer Bundgaard(University of North Carolina at Chapel Hill), Kim Dekermendjian(Lundbeck (Denmark))
Cited by 0
Related Papers
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
|Journal of Medicinal Chemistry|2011|602
Proliferation and differentiation of rat neuroepithelial precursor cells in vivo
|Journal of Neuroscience|1988|560
Immortalization of precursor cells from the mammalian CNS
|Neuron|1988|326
<i>(R)‐N</i>‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier
|Journal of Neurochemistry|1990|228
NNC-711, a novel potent and selective γ-aminobutyric acid uptake inhibitor: pharmacological characterization
|European Journal of Pharmacology|1992|160